Related Experiment Videos
An Integrative Strategy Delineates Modular Metabolic Remodeling and Potential Therapeutic Targets Across Metabolic
Kuan Yang1, Congxue Hu1, Hang Zhao1
1Department of Urology in Cancer Hospital, College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
None:
Metabolic diseases are a substantial global health burden. However, how different metabolic pathways are connected to the clinical relevance in metabolic diseases remains unclear. Here, by integrating previously published single-cell RNA sequencing datasets, a single-cell metabolic atlas including 562 699 cells from 86 patients across seven major metabolic diseases is compiled. An advanced integrative analytical strategy to assess the activity of 227 metabolic pathways is developed. It is identified 89 disease-enriched pathways. These pathways are further organized into 15 cooperative metabolic modules, revealing metabolic module remodeling associated with coordinated pathway activities and underlying regulatory mechanisms. By linking module activities to transcription factor dynamics and ligand-receptor signaling, cross-cell-type regulatory circuits underlying module-specific remodeling and the identification of 63 potential therapeutic targets are delineated. Furthermore, an open-access resource is developed to enable in-depth exploration of the results in this study. In summary, this study illustrates conserved principles of modular metabolic remodeling across metabolic diseases and sheds light on therapeutic target discovery.
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Introduction to Metabolism
Regulation of Metabolism
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...